Skip to content

Author

Hamid Omidian

We have 4 of 47 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Engineering the Biological Identity of Poly(lactic-co-glycolic Acid) Nanocarriers: Protein-Corona Dynamics, Functional Reprogramming, and Translational Fate

Poly(lactic-co-glycolic acid) (PLGA) nanocarriers can be engineered by varying polymer architecture, particle dimensions, surface chemistry, ligands, coatings, and cargo; however, biological exposure subsequently remodels the interface encountered by cells and tissues. This narrative review examines how this acquired b...

Hamid Omidian, Nazanin Kianinejad, Luigi X. Cubeddu · 0 citations
Review Open access Sep 2026

Engineering the oxidative myocardium: ROS-responsive biomaterials for precision cardiovascular delivery in ischemia-reperfusion injury and post-infarction remodeling

Myocardial ischemia-reperfusion injury (MIRI) and post-infarction remodeling are characterized by dynamic oxidative stress that varies across myocardial regions and disease stages. Reactive oxygen species (ROS)-responsive and redox-modulating biomaterials seek to exploit this environment through stimulus-triggered rele...

Hamid Omidian, K. Mfoafo, Luigi X. Cubeddu · 0 citations
Review Open access Jul 2026

Target-Product and Translational Design Principles for Inhalable RNA Nanomedicines

It is argued that the field has moved beyond asking whether RNA can reach the lungs and is best understood as integrated pulmonary products whose success depends on preserving RNA function throughout manufacturing, aerosolization, post-deposition barrier navigation, intracellular delivery, and disease-relevant pharmaco...

Hamid Omidian, Sumana Dey Chowdhury, Luigi X. Cubeddu · 0 citations
Review Open access Aug 2026

Stimuli-responsive bioengineered platforms for precision cancer therapy

The evidence supports a conceptual transition from passive nanocarriers to programmable therapeutic systems capable of aligning therapeutic action with the spatial, temporal, and biological heterogeneity of tumors, but translation remains constrained by formulation complexity, incomplete standardization, limited long-t...

Hamid Omidian, Renae L. Wilson · 1 citation

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.